Tech Company Financing Transactions
Sunflower Therapeutics Funding Round
Sunflower Therapeutics closed a $2 million funding round on 8/4/2026. Investors included National Institutes of Health.
Transaction Overview
Company Name
Announced On
8/4/2026
Transaction Type
Debt
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This Phase II funding will allow Sunflower to build upon its successful Phase I demonstrations to advance automated, continuous bioprocessing technologies that make the production of VLPs more efficient and affordable.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Medford, MA 02155
USA
Medford, MA 02155
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies -- an efficient host, data-driven methods for process development, and continuous biomanufacturing equipment -- our team aims to democratize bioprocessing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kerry Love
Browse more venture capital transactions:
Prev: 8/4/2026: Stella Automotive AI venture capital transaction
Next: 8/4/2026: Yellow Card Financial venture capital transaction
Share this article
About Our VC Transactions Data
We document all VC transactions involving tech companies. All VC database entries on this site come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs